StartUp Health August 23, 2024
A team of scientists and entrepreneurs have developed a superior “brain-in-a-dish” platform that makes the development of therapeutics for diseases like Alzheimer’s and epilepsy much more likely to succeed.
The Challenge
Neurological diseases, such as Alzheimer’s, epilepsy, and brain cancer are devastating conditions with limited treatment options.
Pharmaceutical companies using traditional drug development methods have struggled to develop effective therapies for these conditions in part because the human brain is so complex. Specifically, the brain cells needed to do research have been so difficult to isolate and culture in the lab that neuroscience researchers have been forced to rely heavily on mice and rats. The results, historically, have been less than successful.
That’s where a startup out of Madison,...
Today's Sponsors
Today's Sponsor